{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:06:31Z","timestamp":1777871191765,"version":"3.51.4"},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaad.2025.01.094","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:01:32Z","timestamp":1739934092000},"page":"e209-e210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on \u201c5\u03b1-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study\u201d"],"prefix":"10.1016","volume":"92","author":[{"given":"Austin J.","family":"Coppinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4636-4489","authenticated-orcid":false,"given":"Carlos G.","family":"Wambier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2025.01.094_bib1","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.jaad.2025.02.033","article-title":"5\u03b1-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: a population-based propensity score-matched cohort study","volume":"92","author":"Chen","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.01.094_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00403-024-03542-8","article-title":"Risk of estrogen-driven malignancies in females on 5-alpha reductase inhibitors","volume":"317","author":"Rohan","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"4-5","key":"10.1016\/j.jaad.2025.01.094_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jsbmb.2006.03.010","article-title":"Dutasteride affects progesterone metabolizing enzyme activity\/expression in human breast cell lines resulting in suppression of cell proliferation and detachment","volume":"100","author":"Wiebe","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"10.1016\/j.jaad.2025.01.094_bib4","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/JME-14-0252","article-title":"Progesterone action in breast, uterine, and ovarian cancers","volume":"54","author":"Diep","year":"2015","journal-title":"J Mol Endocrinol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225003159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:04:42Z","timestamp":1777568682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225003159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0190962225003159"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.094","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on \u201c5\u03b1-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: A population-based propensity score-matched cohort study\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.01.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.02.033","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}